Issues regarding ‘immortal time’ in the analysis of the treatment effects in observational studies
Authors:
- Jiannong LiuJiannong Liu
- Eric D. WeinhandlEWEric D. Weinhandl
- David T. GilbertsonDGDavid T. Gilbertson
- Allan J. CollinsACAllan J. Collins
- Wendy L. St PeterWendy L. St Peter
- 1 February 2012
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 81 (4) , 341-350
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Association of Activated Vitamin D Treatment and Mortality in Chronic Kidney DiseaseArchives of internal medicine (1960), 2008
- Association between Multidisciplinary Care and Survival for Elderly Patients with Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2007
- Immortal time bias in observational studies of drug effectsPharmacoepidemiology and Drug Safety, 2007
- Quantifying the impact of survivor treatment bias in observational studiesJournal of Evaluation in Clinical Practice, 2006
- Time-dependent bias was common in survival analyses published in leading clinical journalsJournal of Clinical Epidemiology, 2004
- Inhaled Corticosteroids and the Risk of Mortality and Readmission In Elderly Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Evaluation of Response-Time Data Involving Transient States: An Illustration Using Heart-Transplant DataJournal of the American Statistical Association, 1974
- Does Cardiac Transplantation Prolong Life?Annals of Internal Medicine, 1972
- Cardiac Transplantation in ManAnnals of Internal Medicine, 1971
- SURVIVAL-TIMES AFTER CARDIAC ALLOGRAFTSThe Lancet, 1969